{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:11:13Z","timestamp":1745381473934,"version":"3.40.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-025-02826-y","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:51:17Z","timestamp":1744203077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Off-label use of sodium cantharidinate and vitamin B6 injection in cancer: a protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Wenzhen","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2268-8199","authenticated-orcid":false,"given":"Yiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"12","key":"2826_CR1","first-page":"3855","volume":"22","author":"JJ Wang","year":"2018","unstructured":"Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22(12):3855\u201364.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2826_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10555-021-09969-z","volume":"40","author":"S Giunta","year":"2021","unstructured":"Giunta S. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020. Cancer Metastasis Rev. 2021;40:909\u201324.","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"2826_CR3","doi-asserted-by":"publisher","first-page":"e1700","DOI":"10.1016\/S2214-109X(23)00406-0","volume":"11","author":"C Frick","year":"2023","unstructured":"Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023;11(11):e1700\u201312.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2826_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"2826_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the Global Cancer Statistics 2020. Chin Med J (Engl). 2021;134(7):783\u201391.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"2826_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037\u201348.","journal-title":"Cancer Commun (Lond)"},{"key":"2826_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu J, Hao H, Jiao Y, Li P, Han S. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170: 105728.","journal-title":"Pharmacol Res"},{"key":"2826_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109570","volume":"121","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Q, Chen Y, Liang C, Liu H, Qiu F, et al. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 2020;121: 109570.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2826_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283\u201398.","journal-title":"Biosci Trends"},{"key":"2826_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111044","volume":"133","author":"K Wang","year":"2021","unstructured":"Wang K, Chen Q, Shao Y, Yin S, Liu C, Wang R, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 2021;133: 111044.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2826_CR11","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cam4.2108","volume":"8","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958\u201375.","journal-title":"Cancer Med"},{"issue":"10","key":"2826_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12894","volume":"53","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang S, Wang K, Lu J, Bao X, Wang R, et al. Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products. Cell Prolif. 2020;53(10): e12894.","journal-title":"Cell Prolif"},{"issue":"2","key":"2826_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/092986713804806711","volume":"20","author":"L Deng","year":"2013","unstructured":"Deng L, Dong J, Cai H, Wang W. Cantharidin as an antitumor agent: a retrospective review. Curr Med Chem. 2013;20(2):159\u201366.","journal-title":"Curr Med Chem"},{"issue":"14","key":"2826_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25143279","volume":"25","author":"F Naz","year":"2020","unstructured":"Naz F, Wu Y, Zhang N, Yang Z, Yu C. Anticancer attributes of cantharidin: involved molecular mechanisms and pathways. Molecules. 2020;25(14): 3279.","journal-title":"Molecules"},{"key":"2826_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116012","volume":"32","author":"Y Ren","year":"2021","unstructured":"Ren Y, Kinghorn AD. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives. Bioorg Med Chem. 2021;32: 116012.","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"2826_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.2174\/18715206113139990131","volume":"13","author":"AK Verma","year":"2013","unstructured":"Verma AK, Prasad SB. Changes in glutathione, oxidative stress and mitochondrial membrane potential in apoptosis involving the anticancer activity of cantharidin isolated from redheaded blister beetles, Epicauta hirticornis. Anticancer Agents Med Chem. 2013;13(7):1096\u2013114.","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"2826_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","volume":"101","author":"W Li","year":"2010","unstructured":"Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y, et al. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis. Cancer Sci. 2010;101(5):1226\u201333.","journal-title":"Cancer Sci"},{"issue":"8","key":"2826_CR18","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11427-019-1753-3","volume":"64","author":"X Liu","year":"2021","unstructured":"Liu X, Zhang L, Thu PM, Min W, Yang P, Li J, et al. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Sci China Life Sci. 2021;64(8):1295\u2013310.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"2826_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3892\/or.2017.5779","volume":"38","author":"R Tao","year":"2017","unstructured":"Tao R, Sun WY, Yu DH, Qiu W, Yan WQ, Ding YH, et al. Sodium cantharidinate induces HepG2 cell apoptosis through LC3 autophagy pathway. Oncol Rep. 2017;38(2):1233\u20139.","journal-title":"Oncol Rep"},{"issue":"2","key":"2826_CR20","first-page":"1351","volume":"41","author":"DL Kong","year":"2019","unstructured":"Kong DL, Liu Y, Wang JY, Liu G, Zhang ML. Sodium cantharidinate suppresses human osteosarcoma MG-63 cell proliferation and induces cell cycle arrest by inhibition of PI3K\/AKT activation. Oncol Rep. 2019;41(2):1351\u20138.","journal-title":"Oncol Rep"},{"issue":"6","key":"2826_CR21","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3892\/etm.2017.4294","volume":"13","author":"R Tao","year":"2017","unstructured":"Tao R, Wang ZF, Qiu W, He YF, Yan WQ, Sun WY, et al. Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate. Exp Ther Med. 2017;13(6):2812\u20138.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2826_CR22","first-page":"2273","volume":"15","author":"G Zang","year":"2018","unstructured":"Zang G, Li R, Zhou R, Hao L, He H, Zhang W, et al. Effects of disodium cantharidinate on dendritic cells of patients with bladder carcinoma. Oncol Lett. 2018;15(2):2273\u20137.","journal-title":"Oncol Lett"},{"key":"2826_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/DDDT.S282777","volume":"15","author":"X Chen","year":"2021","unstructured":"Chen X, Zhou M, Fan W, Yang M, Yang L. Combination of sodium cantharidinate with cisplatin synergistically hampers growth of cervical cancer. Drug Des Devel Ther. 2021;15:171\u201383.","journal-title":"Drug Des Devel Ther"},{"issue":"Suppl 1","key":"2826_CR24","first-page":"C79","volume":"10","author":"B Wang","year":"2014","unstructured":"Wang B, Cui J. Treatment of mid-late stage NSCLC using sodium cantharidinate\/vitamin B6\/GP regimen in clinic. J Cancer Res Ther. 2014;10(Suppl 1):C79\u201381.","journal-title":"J Cancer Res Ther"},{"issue":"Suppl 1","key":"2826_CR25","first-page":"75","volume":"10","author":"H Shao","year":"2014","unstructured":"Shao H, Hong G, Luo X. Evaluation of sodium cantharidinate\/vitamin B6 in the treatment of primary liver cancer. J Cancer Res Ther. 2014;10(Suppl 1):75\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"26","key":"2826_CR26","first-page":"12","volume":"17","author":"GW Liu","year":"2017","unstructured":"Liu GW, Ren WD. Cantharis acid sodium vitamin B6 injection comwith maintain capecitabine synchronization for the treatment of advanced colorectal cancer. World Latest Med Inf. 2017;17(26):12\u20134.","journal-title":"World Latest Med Inf"},{"key":"2826_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1037620","volume":"13","author":"C Peng","year":"2022","unstructured":"Peng C, Chen J, Cui W, Li S, Li J, Peng L. Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: a Bayesian network meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13:1037620.","journal-title":"Front Pharmacol"},{"key":"2826_CR28","first-page":"9386273","volume":"2019","author":"Z Wang","year":"2019","unstructured":"Wang Z, Feng F, Wu Q, Jin Y, Gu C, Xu Y, et al. Disodium cantharidinate and vitamin B6 injection adjunct with platinum-based chemotherapy for the treatment of advanced non-small-cell lung cancer: a meta-analysis. Evid Based Complement Alternat Med. 2019;2019:9386273.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"2826_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jcpt.12761","volume":"44","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Wang C, Tan Z, Hu S, Chen Y, Zhou M, et al. Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: a systematic review and meta-analysis of 38 randomized controlled trials. J Clin Pharm Ther. 2019;44(1):23\u201338.","journal-title":"J Clin Pharm Ther"},{"key":"2826_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/DDDT.S190674","volume":"13","author":"M Liu","year":"2018","unstructured":"Liu M, Xu C, Sun Y. Efficacy and safety of sodium cantharidinate and vitamin B6 injection for the treatment of digestive system neoplasms: a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2018;13:183\u2013203.","journal-title":"Drug Des Devel Ther"},{"key":"2826_CR31","first-page":"7","volume":"4","author":"YF Wang","year":"2016","unstructured":"Wang YF, Yang XH, Liu F, Yu F. Meta-analysis of the treatment of primary liver cancer with aiyishu injection combined with chemotherapy. Chin J Prev Med. 2016;4:7 ((in Chinese)).","journal-title":"Chin J Prev Med"},{"issue":"5\u20136","key":"2826_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.phrs.2008.09.007","volume":"58","author":"A Neubert","year":"2008","unstructured":"Neubert A, Wong IC, Bonifazi A, Catapano M, Felisi M, Baiardi P, et al. Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res. 2008;58(5\u20136):316\u201322.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2826_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jcpt.12507","volume":"42","author":"MM Saiyed","year":"2017","unstructured":"Saiyed MM, Ong PS, Chew L. Off-label drug use in oncology: a systematic review of literature. J Clin Pharm Ther. 2017;42(3):251\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"2826_CR34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00228-014-1729-3","volume":"70","author":"H Wu","year":"2014","unstructured":"Wu H, Wu G. Strategy to address innovative off-label medication use in China: grading management. Eur J Clin Pharmacol. 2014;70(10):1271\u20133.","journal-title":"Eur J Clin Pharmacol"},{"key":"2826_CR35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fphar.2019.01210","volume":"10","author":"M Herrero Fernandez","year":"2019","unstructured":"Herrero Fernandez M, Molina Villaverde R, Arroyo Yustos M, Navarro Exp\u00f3sito F, Lopez Gonzalez JL, Luque Infantes MR, et al. The off-label use of antineoplastics in oncology is limited but has notable scientific support in a university hospital setting. Front Pharmacol. 2019;10:1210.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2826_CR36","first-page":"3","volume":"25","author":"SY Qian","year":"2018","unstructured":"Qian SY, Yang M. Current situation and principles of off-label drug use. Chin J Emerg Pediatr. 2018;25(1):3 (in Chinese).","journal-title":"Chin J Emerg Pediatr."},{"key":"2826_CR37","first-page":"256","volume":"11","author":"ZM Wu","year":"2013","unstructured":"Wu ZM, Liu Q, Shi SM, Yu SY. Clinical study of ai yishu combined with FOLFIRI regimen in the treatment of recurrent gastric cancer. Medical Information. 2013;11:256\u2013256 (in Chinese).","journal-title":"Medical Information"},{"key":"2826_CR38","first-page":"2","volume":"1","author":"GP Li","year":"2010","unstructured":"Li GP, Li XR, Wang JH. Clinical observation on sodium cantharidate vitamin B6 injection combined with postoperative chemotherapy in treatment of gastric cancer. Practical Preventive Medicine. 2010;1:2 (in Chinese).","journal-title":"Practical Preventive Medicine"},{"issue":"11","key":"2826_CR39","first-page":"4","volume":"31","author":"Y Chen","year":"2016","unstructured":"Chen Y, Zhu WM, Zhou DX, Shan YF. Clinical study on disodium cantharidinate and vitamin B6 combined with raltitrexed and oxaliplatin in treatment of advanced colorectal cancer. Drugs, Clinic. 2016;31(11):4 (in Chinese).","journal-title":"Drugs, Clinic."},{"issue":"26","key":"2826_CR40","first-page":"3","volume":"17","author":"GW Liu","year":"2017","unstructured":"Liu GW, Ren WD. Cantharis acid sodium vitamin B6 injection combined with maintain capecitabine synchronization for the treatment of advanced colorectal cancer. World Latest Med Inform. 2017;17(26):3 (in Chinese).","journal-title":"World Latest Med Inform"},{"issue":"3","key":"2826_CR41","first-page":"3","volume":"42","author":"H Zhu","year":"2014","unstructured":"Zhu H, Zhang HY, He M, Chen X. Effects of sodium cantharidinate and vitamin B6 injection on plasma D-dimer level in patients of advanced esophageal cancer after chemotherapy. Tianjin Med J. 2014;42(3):3 (in Chinese).","journal-title":"Tianjin Med J"},{"issue":"021","key":"2826_CR42","first-page":"188","volume":"000","author":"JM Jia","year":"2013","unstructured":"Jia JM, Li ZH. Effect of sodium cantharidinate and vitamin B6 combined with intravenous chemotherapy in the treatment of advanced esophageal cancer. Medical Information. 2013;000(021):188\u20139 (in Chinese).","journal-title":"Medical Information"},{"issue":"20","key":"2826_CR43","first-page":"2","volume":"24","author":"LY Guan","year":"2015","unstructured":"Guan LY, Ma J, Yuan SF, Qu JR. Disodium cantharidinate and vitamin B6 combined with tegafur, gimeracil and oteracil potassium for treating stage IV pancreatic cancer in 27 cases. China Pharm. 2015;24(20):2 (in Chinese).","journal-title":"China Pharm"},{"issue":"12","key":"2826_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010127","volume":"97","author":"D Zhang","year":"2018","unstructured":"Zhang D, Wu J, Wang K, Duan X, Liu S, Zhang B. Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis. Medicine (Baltimore). 2018;97(12): e0127.","journal-title":"Medicine (Baltimore)"},{"issue":"40","key":"2826_CR45","doi-asserted-by":"publisher","first-page":"68873","DOI":"10.18632\/oncotarget.20320","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Zheng J, Ni M, Wu J, Wang K, Duan X, et al. Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis. Oncotarget. 2017;8(40):68873\u201389.","journal-title":"Oncotarget"},{"key":"2826_CR46","first-page":"039","volume":"007","author":"QD Gao","year":"2022","unstructured":"Gao QD, Kang F. Effects of disodium cantharidinate and vitamin B6 injection on tumor markers and adverse reactions during SOX regimen in the treatment of breast cancer. J Clin Res. 2022;007:039 (in Chinese).","journal-title":"J Clin Res"},{"issue":"5","key":"2826_CR47","first-page":"5","volume":"28","author":"CY Quan","year":"2019","unstructured":"Quan CY, Qiu XP, Zhang ZQ, Du ZY. Effect of sodium cantharidinate and vitamin B6 in the treatment of advanced breast cancer and its impact on quality of life and safety. Chinese Journal of General Surgery. 2019;28(5):5 (in Chinese).","journal-title":"Chinese Journal of General Surgery."},{"issue":"12","key":"2826_CR48","first-page":"4","volume":"21","author":"Y Li","year":"2015","unstructured":"Li Y, Zhang T, Guo YP, Liu L, Zhu JH, Zhao Y, et al. Effect of cantharidin sodium vitamin B6 combing with PT therapy on the lymphatic growth factor of ovarian cancer tissues. Journal of Hainan Medical University. 2015;21(12):4 (in Chinese).","journal-title":"Journal of Hainan Medical University"},{"issue":"9","key":"2826_CR49","first-page":"3","volume":"29","author":"YT Shao","year":"2016","unstructured":"Shao YT, Wang LY. Short term efficacy of sodium cantharidinate and vitamin B6 combined with PT regimen in the treatment of epithelial ovarian cancer. Chin J Clin Res. 2016;29(9):3 (in Chinese).","journal-title":"Chin J Clin Res"},{"key":"2826_CR50","unstructured":"Jiang HL, Huang H. Effect of sodium cantharidate vitamin B6 injections in adjuvant treatment of advanced cervical cancer. Chinese Pharmacist. 2014;(11):1904\u201306. (in Chinese)."},{"key":"2826_CR51","unstructured":"Luo XN, Zhang Y, Guo Z. Efficacy of sodium cantharidinate and vitamin B6 combined with concurrent chemoradiotherapy in the treatment of advanced cervical cancer. Journal of Jiangxi University of CM. 2022. (in Chinese)"},{"issue":"4","key":"2826_CR52","first-page":"4","volume":"29","author":"ZT Mi","year":"2017","unstructured":"Mi ZT, Zang ZF, Zhang XF, Liang JZ, Zhang SY, Fan L. Effect observation of sodium cantharidate and vitamin B6 combined with concurrent chemoradiotherapy in treatment of locally advanced nasopharyngeal carcinoma. Cancer Research and Clinic. 2017;29(4):4 (in Chinese).","journal-title":"Cancer Research and Clinic"},{"issue":"7","key":"2826_CR53","first-page":"4","volume":"36","author":"XZ Ying","year":"2016","unstructured":"Ying XZ, Xu YP, Wu H, Lin X, Bao LM. Clinical application value of disodium cantharidinate and vitamin B6 chemotherapy in nasopharyngeal carcinoma. Chin J Biochem Pharm. 2016;36(7):4 (in Chinese).","journal-title":"Chin J Biochem Pharm"},{"key":"2826_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115726","volume":"430","author":"JL Pang","year":"2021","unstructured":"Pang JL, Huang FH, Zhang YH, et al. Sodium cantharidate induces apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5\u2013p53 axis. Toxicol Appl Pharmacol. 2021;430: 115726.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2826_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1000377","volume":"13","author":"JL Pang","year":"2022","unstructured":"Pang JL, Xu LS, Zhao Q, et al. Sodium cantharidate promotes autophagy in breast cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway. Front Pharmacol. 2022;13: 1000377.","journal-title":"Front Pharmacol"},{"issue":"7","key":"2826_CR56","first-page":"487","volume":"33","author":"JR Hua","year":"2024","unstructured":"Hua JR, Chen HM, Huang XM, Chen J, Tu YX, Wang LQ, et al. The mechanism of sodium cantharidinate in inducing apoptosis related gene expression in human cervical cancer HeLa cells. Proceeding of Clinical Medicine. 2024;33(7):487\u201391 (in Chinese).","journal-title":"Proceeding of Clinical Medicine"},{"issue":"4","key":"2826_CR57","first-page":"5","volume":"24","author":"TP He","year":"2005","unstructured":"He TP, Mo LE, Liang NC. Inhibitory effect of cantharidin on invasion and metastasis of highly metastatic ovarian carcinoma cell line HO-8910PM. Chin J Cancer. 2005;24(4):5 (in Chinese).","journal-title":"Chin J Cancer"},{"issue":"5","key":"2826_CR58","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/tox.22897","volume":"35","author":"YC Chen","year":"2020","unstructured":"Chen YC, Chen PN, Lin CW, et al. Cantharidic acid induces apoptosis in human nasopharyngeal carcinoma cells through p38-mediated upregulation of caspase activation. Environ Toxicol. 2020;35(5):619\u201327.","journal-title":"Environ Toxicol"},{"issue":"1","key":"2826_CR59","first-page":"74","volume":"41","author":"XY Wu","year":"2014","unstructured":"Wu XY, Lin WY, Nong QW, Tang RF, Wu ZM. Clinical observation of sodium cantharidate vitamin B6 injection combined wim chemotherapy for acute leukemia patients. J Int Oncol. 2014;41(1):74\u20136 (in Chinese).","journal-title":"J Int Oncol"},{"key":"2826_CR60","first-page":"2","volume":"23","author":"JH Yan","year":"2014","unstructured":"Yan JH, Li P, Wu GH. Clinical observation of sodium cantharidinate and vitamin B6 injection combined with CAG regimen in the treatment of elderly patients with acute myeloid leukemia. Medical Information. 2014;23:2 (in Chinese).","journal-title":"Medical Information"},{"issue":"6","key":"2826_CR61","first-page":"4","volume":"20","author":"M Zhong","year":"2014","unstructured":"Zhong M, Xu QL, Su QH. Effect of Cantharis acid sodium vitamin B6 combined with CHOP chemotherapy on non-Hodgkin\u2019s lymphoma. J Hainan Med Univ. 2014;20(6):4 (in Chinese).","journal-title":"J Hainan Med Univ"},{"key":"2826_CR62","first-page":"2","volume":"24","author":"JH Yan","year":"2014","unstructured":"Yan JH, Li P, Wu GH. Clinical observation of sodium cantharidinate and vitamin B6 injection combined with CHOP chemotherapy on non-Hodgkin\u2019s lymphoma. Medical Information. 2014;24:2 (in Chinese).","journal-title":"Medical Information"},{"key":"2826_CR63","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3389\/fphar.2020.01321","volume":"11","author":"Z Yu","year":"2020","unstructured":"Yu Z, Li L, Wang C, et al. Cantharidin induces apoptosis and promotes differentiation of AML cells through nuclear receptor Nur77-mediated signaling pathway. Front Pharmacol. 2020;11:1321.","journal-title":"Front Pharmacol"},{"issue":"16","key":"2826_CR64","first-page":"3","volume":"14","author":"SJ Wei","year":"2007","unstructured":"Wei SJ, Shi AC. Study on reversal and mechanism of reversing multidrug-resistant human leukemia cell line K562\/AO2 by disodium cantharidinate and vitamin B6 injection. Chin J Cancer Prev Treat. 2007;14(16):3.","journal-title":"Chin J Cancer Prev Treat"},{"issue":"7","key":"2826_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009099","volume":"12","author":"M Zhu","year":"2024","unstructured":"Zhu M, Tang W, Tang X, et al. Cantharidin overcomes IL-2R\u03b1 signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species. J Immunother Cancer. 2024;12(7): e009099.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2826_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1): 1.","journal-title":"Syst Rev"},{"key":"2826_CR67","doi-asserted-by":"publisher","first-page":"6037037","DOI":"10.1155\/2017\/6037037","volume":"2017","author":"YF Liu","year":"2017","unstructured":"Liu YF, Huang Y, Wen CYZ, Zhang JJ, Xing GL, Tu SH, et al. The effects of modified Simiao decoction in the treatment of gouty arthritis: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2017;2017:6037037.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"2826_CR68","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/ma14123234","volume":"14","author":"G Gonz\u00e1lez-Valls","year":"2021","unstructured":"Gonz\u00e1lez-Valls G, Roca-Millan E, C\u00e9spedes-S\u00e1nchez JM, Gonz\u00e1lez-Navarro B, Torrejon-Moya A, L\u00f3pez-L\u00f3pez J. Narrow diameter dental implants as an alternative treatment for atrophic alveolar ridges. Syst review and meta-analysis Materials (Basel). 2021;14(12):3234.","journal-title":"Syst review and meta-analysis Materials (Basel)"},{"key":"2826_CR69","unstructured":"National Medical Products Administration (NMPA), Center for Drug Evaluation (CDE). Statistical design guidance for clinical trials of anticancer drugs (Trial Version). 2020. [Online]. Available at: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/b8a33e6df753b13e091b83b8d5a412f8."},{"key":"2826_CR70","unstructured":"Food and Drug Administration. Clinical trial endpoints for the approval of cancer drugs and biologics guidance for industry. 2018. Retrieved from https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-trial-endpoints-approval-cancer-drugs-and-biologics."},{"key":"2826_CR71","unstructured":"European Medicines Agency. Guideline on the clinical evaluation of anticancer medicinal products - Revision 6. 2024. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-evaluation-anticancer-medicinal-products-revision-6_en.pdf"},{"issue":"4","key":"2826_CR72","first-page":"220","volume":"27","author":"JK Clancey","year":"1995","unstructured":"Clancey JK. Karnofsky performance scale. J Neurosci Nurs. 1995;27(4):220.","journal-title":"J Neurosci Nurs"},{"issue":"5","key":"2826_CR73","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s10637-020-00907-4","volume":"38","author":"GL Uy","year":"2020","unstructured":"Uy GL, Assouline S, Young AM, et al. Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia. Invest New Drugs. 2020;38(5):1430\u201341.","journal-title":"Invest New Drugs"},{"key":"2826_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1034253","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zhou H, Mu M, et al. Efficacy and safety of copanlisib in relapsed\/refractory B-cell non-Hodgkin lymphoma: a meta-analysis of prospective clinical trials. Front Immunol. 2022;13: 1034253.","journal-title":"Front Immunol"},{"key":"2826_CR75","doi-asserted-by":"publisher","unstructured":"WHO-toxicity scale. In: Dictionary of pharmaceutical medicine. Springer, Vienna. https:\/\/doi.org\/10.1007\/978-3-211-89836-9_1474.","DOI":"10.1007\/978-3-211-89836-9_1474"},{"key":"2826_CR76","unstructured":"National Cancer Institue. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. U.S. Department of Health and Human Services; 2017. Retrieved from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"issue":"6","key":"2826_CR77","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/gerona\/glaa128","volume":"76","author":"LJ Chen","year":"2021","unstructured":"Chen LJ, Trares K, Laetsch DC, Nguyen TNM, Brenner H, Sch\u00f6ttker B. Systematic review and meta-analysis on the associations of polypharmacy and potentially inappropriate medication with adverse outcomes in older cancer patients. J Gerontol A Biol Sci Med Sci. 2021;76(6):1044\u201352.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"2826_CR78","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jclinepi.2014.12.017","volume":"68","author":"CW Halladay","year":"2015","unstructured":"Halladay CW, Trikalinos TA, Schmid IT, Schmid CH, Dahabreh IJ. Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions. J Clin Epidemiol. 2015;68(9):1076\u201384.","journal-title":"J Clin Epidemiol"},{"key":"2826_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2022.101895","volume":"9","author":"A Carrera-Rivera","year":"2022","unstructured":"Carrera-Rivera A, Ochoa W, Larrinaga F, Lasa G. How-to conduct a systematic literature review: a quick guide for computer science research. MethodsX. 2022;9: 101895.","journal-title":"MethodsX"},{"issue":"1","key":"2826_CR80","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","volume":"6","author":"WM Bramer","year":"2017","unstructured":"Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. 2017;6(1):245.","journal-title":"Syst Rev"},{"issue":"1","key":"2826_CR81","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12877-020-01747-w","volume":"20","author":"N Morkisch","year":"2020","unstructured":"Morkisch N, Upegui-Arango LD, Cardona MI, et al. Components of the transitional care model (TCM) to reduce readmission in geriatric patients: a systematic review. BMC Geriatr. 2020;20(1):345 Published 2020 Sep 11.","journal-title":"BMC Geriatr"},{"issue":"2","key":"2826_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaoncol.2019.5233","volume":"6","author":"Y He","year":"2020","unstructured":"He Y, Guo X, May BH, et al. Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis. JAMA Oncol. 2020;6(2):271\u20138.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2826_CR83","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/apjon.apjon-2130","volume":"8","author":"B Xu","year":"2021","unstructured":"Xu B, Cheng Q, So WKW. Review of the effects and safety of traditional Chinese medicine in the treatment of cancer cachexia. Asia Pac J Oncol Nurs. 2021;8(5):471\u201386.","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"7","key":"2826_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"PRISMA Group","year":"2009","unstructured":"PRISMA Group. Preferred Reporting Items for Systematic reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med."},{"issue":"1","key":"2826_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041607","volume":"11","author":"B Sch\u00f6ttker","year":"2021","unstructured":"Sch\u00f6ttker B, Kuznia S, Brenner H. Efficacy of vitamin D3 supplementation on cancer mortality in the general population and the prognosis of patients with cancer: protocol of a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ Open. 2021;11(1): e041607.","journal-title":"BMJ Open"},{"issue":"1","key":"2826_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13643-024-02471-x","volume":"13","author":"JJE Moors","year":"2024","unstructured":"Moors JJE, Xu Z, Xie K, et al. Full-thickness skin graft versus split-thickness skin graft for radial forearm free flap donor site closure: protocol for a systematic review and meta-analysis. Syst Rev. 2024;13(1):74.","journal-title":"Syst Rev"},{"key":"2826_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8: 16.","journal-title":"Trials"},{"key":"2826_CR88","unstructured":"Deeks JJ, Higgins JPT, Altman DG. (Eds.). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (Eds.). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (Updated August 2023). Cochrane, 2023. Retrieved from: https:\/\/training.cochrane.org\/handbook."},{"issue":"1","key":"2826_CR89","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13643-020-01571-8","volume":"10","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhou MM, Xia R, Bai JH, Yan LH. Gabapentin for phantom limb pain after amputation in pediatric oncology: a systematic review protocol. Syst Rev. 2021;10(1):26.","journal-title":"Syst Rev"},{"issue":"3","key":"2826_CR90","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1684\/ejd.2019.3553","volume":"29","author":"M Hou","year":"2019","unstructured":"Hou M, Xing H, Cai Y, Wang X, Xie Z, Zhang Q, et al. Short-term effect and safety of a new generation of monoclonal antibodies targeting interleukin-23p19 for treatment of psoriasis: a systematic review and meta-analysis. Eur J Dermatol. 2019;29(3):302\u201314.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"2826_CR91","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","volume":"168","author":"RT Ras","year":"2013","unstructured":"Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168(1):344\u201351.","journal-title":"Int J Cardiol"},{"issue":"11","key":"2826_CR92","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2215\/CJN.09250914","volume":"10","author":"JJ Zhang","year":"2015","unstructured":"Zhang JJ, Ma XX, Hao L, Liu LJ, Lv JC, Zhang H. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol. 2015;10(11):1964\u201378.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2826_CR93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02826-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:16:55Z","timestamp":1745299015000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02826-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02826-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}